Alfred J. Ford Jr.
Net Worth
Last updated:
What is Alfred J. Ford Jr. net worth?
The estimated net worth of Mr. Alfred J. Ford Jr. is at least $13,156,715 as of 31 Jan 2024. He has earned $10,309,915 from insider trading and has received compensation worth at least $2,846,800 in Axonics, Inc..
What is the salary of Alfred J. Ford Jr.?
Mr. Alfred J. Ford Jr. salary is $569,360 per year as Chief Commercial Officer in Axonics, Inc..
How old is Alfred J. Ford Jr.?
Mr. Alfred J. Ford Jr. is 54 years old, born in 1971.
What stocks does Alfred J. Ford Jr. currently own?
As insider, Mr. Alfred J. Ford Jr. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Axonics, Inc. (AXNX) | Chief Commercial Officer | 43,450 | $0 | $0 |
What does Axonics, Inc. do?
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Alfred J. Ford Jr. insider trading
Axonics, Inc.
Mr. Alfred J. Ford Jr. has made 19 insider trades between 2020-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 54,296 units of AXNX stock on 19 Apr 2021. As of 31 Jan 2024 he still owns at least 43,450 units of AXNX stock.
Axonics key executives
Axonics, Inc. executives and other stock owners filed with the SEC:
- Dr. Karen L. Noblett M.D., M.A.S. (62) Chief Medical Officer
- Mr. Alfred J. Ford Jr. (54) Chief Commercial Officer
- Mr. Danny L. Dearen (62) Pres & Chief Financial Officer
- Mr. Raymond W. Cohen (66) Chief Executive Officer & Director
- Mr. Rinda K. Sama (46) Chief Operating Officer